Tian'an Pharmaceutical Co Ltd
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chi… Read more
Tian'an Pharmaceutical Co Ltd (TNPH) - Total Liabilities
Latest total liabilities as of December 2024: $91.36K USD
Based on the latest financial reports, Tian'an Pharmaceutical Co Ltd (TNPH) has total liabilities worth $91.36K USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tian'an Pharmaceutical Co Ltd - Total Liabilities Trend (2004–2024)
This chart illustrates how Tian'an Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tian'an Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tian'an Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Schroders Capital Global Innovation Trust plc - INOV
LSE:INOV
|
UK | GBX898.00K |
|
Empire East Land Holdings Inc
PSE:ELI
|
Philippines | ₱19.98 Billion |
|
Torque Lifestyle Brands Inc
PINK:TQLB
|
USA | $24.03K |
Liability Composition Analysis (2004–2024)
This chart breaks down Tian'an Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 16.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tian'an Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tian'an Pharmaceutical Co Ltd (2004–2024)
The table below shows the annual total liabilities of Tian'an Pharmaceutical Co Ltd from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $91.36K | -78.50% |
| 2023-12-31 | $425.00K | +103.84% |
| 2022-12-31 | $208.49K | -60.09% |
| 2021-12-31 | $522.35K | +207.57% |
| 2020-12-31 | $169.83K | +26.18% |
| 2019-12-31 | $134.60K | +8843.26% |
| 2018-12-31 | $1.50K | -99.82% |
| 2007-12-31 | $853.05K | +46.43% |
| 2006-12-31 | $582.58K | -12.19% |
| 2005-12-31 | $663.44K | +109.76% |
| 2004-12-31 | $316.29K | -- |